Qin Lu Selected Research

human MIRN1 microRNA

6/2016

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qin Lu Research Topics

Disease

52	Neoplasms (Cancer) 03/2022 - 12/2005
9	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 01/2014
9	Infections 01/2022 - 01/2007
9	Ventilator-Associated Pneumonia 01/2021 - 10/2009
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 04/2002
8	Critical Illness (Critically Ill) 01/2021 - 02/2003
8	Acute Lung Injury 12/2012 - 02/2003
7	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2014
7	Pneumonia (Pneumonitis) 04/2018 - 10/2009
6	Cerebral Hemorrhage 11/2022 - 03/2014
6	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2010
6	Inflammation (Inflammations) 12/2021 - 12/2012
6	Necrosis 10/2020 - 03/2007
5	Hemorrhage 03/2020 - 08/2008
4	Stomach Neoplasms (Stomach Cancer) 06/2022 - 02/2012
4	Stroke (Strokes) 10/2021 - 10/2017
4	Brain Injuries (Brain Injury) 10/2021 - 03/2014
4	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 05/2018
4	Gliosis 10/2017 - 01/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022 - 02/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 07/2015
3	Wounds and Injuries (Trauma) 11/2021 - 02/2013
3	Brain Edema (Cerebral Edema) 09/2021 - 10/2020
3	Hepatitis B 01/2021 - 03/2008
3	Edema (Dropsy) 12/2020 - 12/2012
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2013 - 03/2010
3	Hepatocellular Carcinoma (Hepatoma) 04/2009 - 12/2005
2	Melanoma (Melanoma, Malignant) 03/2022 - 03/2014
2	Prurigo 01/2022 - 11/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2020
2	Ischemic Stroke 01/2021 - 04/2016
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 10/2020
2	Sepsis (Septicemia) 01/2020 - 10/2017
2	Leukemia 02/2019 - 01/2010
2	Hypoxia (Hypoxemia) 08/2018 - 01/2008

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 03/2022 - 04/2009
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2010
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2013
8	Peptides (Polypeptides)IBA 12/2020 - 03/2010
6	CytokinesIBA 03/2021 - 03/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2010
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 03/2010
5	Angiogenesis InhibitorsIBA 01/2016 - 03/2010
4	Biological ProductsIBA 10/2021 - 09/2015
4	Small Interfering RNA (siRNA)IBA 08/2018 - 07/2014
4	Colistin (Coly-Mycin)FDA Link 12/2016 - 07/2010
3	Messenger RNA (mRNA)IBA 08/2022 - 01/2020
3	EnzymesIBA 03/2022 - 01/2019
3	AcidsIBA 03/2022 - 12/2012
3	SaponinsIBA 01/2021 - 01/2015
3	NucleotidesIBA 01/2021 - 03/2010
3	TriterpenesIBA 01/2021 - 02/2013
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2008
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 07/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2010
3	AerosolsIBA 01/2018 - 07/2010
3	Long Noncoding RNAIBA 12/2017 - 03/2016
3	Caspase 3 (Caspase-3)IBA 06/2017 - 12/2005
3	LigandsIBA 02/2015 - 03/2010
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2022 - 10/2021
2	aloperineIBA 02/2022 - 01/2021
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 01/2010
2	Cortisone FDA Link 01/2022 - 11/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 11/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 04/2009
2	Nonesterified Fatty Acids (NEFA)IBA 12/2021 - 07/2021
2	coumarinIBA 10/2021 - 11/2014
2	Hemoglobins (Hemoglobin)IBA 09/2021 - 06/2016
2	Phosphotransferases (Kinase)IBA 01/2021 - 09/2015
2	Amikacin (A.M.K)FDA LinkGeneric 01/2021 - 07/2011
2	LDL CholesterolIBA 12/2020 - 04/2016
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 12/2020 - 10/2020
2	CholesterolIBA 12/2020 - 04/2016
2	Interleukin-8 (Interleukin 8)IBA 10/2020 - 01/2020
2	InterleukinsIBA 10/2020 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2019
2	Genetic Markers (Genetic Marker)IBA 01/2020 - 06/2011
2	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020 - 04/2019
2	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 09/2015
2	CreatinineIBA 01/2020 - 12/2019
2	Deubiquitinating EnzymesIBA 11/2019 - 04/2019
2	Ubiquitin-Specific ProteasesIBA 11/2019 - 04/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 04/2016
2	Potassium Channels (Potassium Channel)IBA 10/2017 - 01/2016
2	Intermediate-Conductance Calcium-Activated Potassium ChannelsIBA 10/2016 - 01/2016
2	NitrogenIBA 06/2016 - 01/2011
2	AntibodiesIBA 01/2015 - 12/2005

Therapy/Procedure

28	Therapeutics 07/2022 - 04/2009
10	Drug Therapy (Chemotherapy) 03/2022 - 03/2010
9	Artificial Respiration (Mechanical Ventilation) 01/2021 - 07/2004
8	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2020 - 04/2002
3	Immunotherapy 01/2022 - 03/2008
3	Intravenous Injections 01/2022 - 02/2003
3	Intravenous Administration 07/2010 - 02/2008
2	Hematopoietic Stem Cell Transplantation 12/2022 - 02/2019
2	Photochemotherapy (Photodynamic Therapy) 01/2021 - 08/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2016 - 02/2011